French healthtech innovator LifeAz has raised €13 million in fresh funding to turbocharge its mission of equipping everyday citizens with tools and training for emergency interventions. This latest round positions the startup at the forefront of a vital push to bridge critical gaps in cardiac care, making defibrillators and first-aid skills as accessible as a smartphone app.

A Mission Born from Tragedy and Ingenuity

Flash back to 2015: three visionary engineers—Johann Kalchman, Timothée Soubise, and Martial Itty—watched helplessly as cardiac arrests claimed lives in homes where help was minutes away. In France alone, 40,000 out-of-hospital cardiac arrests occur yearly, with survival rates hovering at a dismal 5-10% due to delayed defibrillation. Their response? LifeAz, a holistic platform blending connected defibrillators, online training, and community networks to empower non-experts as first responders.​

What sets LifeAz apart is its “3-pillar” approach: ultra-user-friendly AEDs like Clark (plug-and-play, voice-guided, app-linked), bite-sized digital courses on CPR and gestures that save lives, and a geo-localized map crowdsourcing device locations for rescuers. Backed by a scientific committee from Paris’ Hôpital Jacques Cartier and Red Cross experts, the startup earned MIT’s nod as a top French innovation in 2017, plus accolades from Allianz and Cisco. From bootstrapped beginnings, LifeAz scaled to thousands of units deployed, partnerships with mutuelles, and European ambitions.​

Funding Fuel: From €4M to €13M Scale-Up

This €13M raise—details emerging from Tech.eu on February 12, 2026—builds on prior successes, including a €4M round in 2021 led by XAnge (Impact fund via Mutuelles Impact) alongside Investir&+ and business angels. New investors join to accelerate R&D, hiring (aiming for 30+ heads), marketing blitzes, and pan-EU rollout. Expect intensified e-commerce, physical retail tie-ups, and mutuelle collaborations to slash AED costs via subsidies and insurance perks.​

Funds target “impact at scale”: smarter sensors for AEDs, AI-enhanced training simulations, and data platforms tracking intervention efficacy. Johann Kalchman notes this capital arrives “at a pivotal moment,” enabling desert médical coverage and urban densification alike. Nadja Bresous of XAnge praises the blend of profitability and societal ROI, while Vincent Fauvet of Investir&+ spotlights equity in underserved zones.​

Financial trajectory? Post-2021, LifeAz ramped deployments, hit profitability milestones, and eyed exports. This infusion projects exponential growth, mirroring healthtech peers like Withings or Alan in blending consumer tech with clinical impact.

Clark: The Defibrillator Reinvented for the Masses

Meet Clark, LifeAz’s flagship: a wall-mountable, connected AED that’s as intuitive as Alexa. No training needed—voice prompts in multiple languages guide users step-by-step, while the app notifies nearby trained volunteers and emergency services. Battery auto-checks, cloud analytics predict maintenance, and tamper-proof design suits homes, offices, schools, or cars.

Beyond hardware, LifeAz’s app offers 15-minute modules on Heimlich, choking, burns—gamified for retention. The “survival chain” map pinpoints AEDs within 200m, integrating with 112 services. In tests, first-time users succeed 90%+ vs. traditional 50%. Priced affordably (€500-1000, with financing), it’s no luxury—it’s insurance for the irreplaceable.​

Real impact? Pilots in French communes boosted response times 50%, saving simulated lives. As EU mandates public AEDs, LifeAz leads private adoption, targeting 1 million units by 2030.

Europe’s Cardiac Crisis: A Call to Arms

Out-of-hospital arrests kill 400,000 Europeans annually; survival triples with AED use within 3-5 minutes, yet only 1% of homes have one. France lags neighbors like Denmark (public AED density 10x higher). Regulations help—2023 laws require schools/hotels to equip—but homes remain blind spots, especially rural “déserts médicaux.”

LifeAz flips this: consumerize via e-commerce (Amazon, pharmacies), B2B for enterprises, and public-private hybrids. Competitors like iAED or HeartSine focus hardware; LifeAz owns the ecosystem—device + education + network. Post-funding, watch Spain, Germany, Italy entries, leveraging GDPR-compliant data for smarter alerts.​

Tailwinds abound: EU Horizon funds for medtech, rising insurer reimbursements, and post-COVID health consciousness. Challenges? Awareness gaps, regulatory harmonization—but LifeAz’s track record (lauréat Concours Innovation Numérique) de-risks execution.

Strategic Expansions and Ecosystem Plays

€13M unlocks hires in AI/ML for predictive maintenance, sales teams for mutuelle deals, and marketing to normalize “every home an ER.” Integrations loom: wearables (Apple Watch false positives trigger Clark), smart homes (Alexa summons), telemed tie-ins. Backward? Manufacture ramp in France for sovereignty.

Investor synergy shines: XAnge’s deeptech portfolio (Gleamer, Wandercraft), Investir&+’s social bets (Yuka, HelloAsso). LifeAz joins impact unicorns proving profit + purpose scales—€4M begat deployments; €13M births a network effect.

For MarTech pros eyeing adjacencies, LifeAz echoes predictive AI: data from 1000s interventions refines algorithms, much like Validity’s Engage benchmarks emails. Citizen health platforms could gamify wellness, monetize via premiums.

Pioneering a Survivor-First Future

Envision a Paris apartment: cardiac event strikes; Clark activates, app pings neighbor Sam (CPR-certified), ambulance en route—survival odds soar. Or rural Auvergne: map guides hiker to nearest AED. LifeAz isn’t selling devices; it’s scripting happy endings.